MDDI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Supplier Stories for the Week of May 19

Here’s what was new in the world of medical device suppliers during the week of May 19.

  • Vision Engineering’s DRV (Deep Reality Viewer) creates stereo high-definition 3D images without using a monitor or requiring operators to wear headsets or specialist glasses, as images ‘float’ in front of a mirror. Developed to address quality control and production requirements in sectors including medical, electronics, and other industries, DRV offers full, real-time transferability of information to multi-site manufacturers, designers, or users of multi-tier development and logistic capabilities. The company anticipates the system could be of interest to users who model and test components in 3D as well as those working to improve manufacturing processes. DRV can provide real-time, full HD 3D stereo images to multiple users in different locations at the same time.

    Using Vision Engineering’s globally patented TriTeQ3 digital 3D display technology, the DRV-Z1 (Zoom model 1) incorporates a zoom microscope module.

    “Over the past 60 years Vision Engineering has built its reputation on the innovation, quality, performance, and ergonomics of our visual inspection and metrology systems," stated Mark Curtis, managing director of Vision Engineering, in a news release. "DRV-Z1 provides enhanced 3D visualization and overcomes current problems with 3D modelling and inspection systems. By amalgamating our existing technologies, we’ve delivered an entirely new concept to our existing customer base, as well as opening up opportunities in fresh markets.”

    [Image courtesy of VISION ENGINEERING]

    Editor's Note: If you have news you’d like to submit for potential inclusion in future weekly roundups, please send a press release and any related images to [email protected] with the subject line “Supplier Stories.”

  • IME Medical Electrospinning is launching the MediSpin XL platform for large-scale industrial manufacturing of reproducible and scalable fiber-based scaffolds for Class I, II, and III medical devices. The platform supports controlled large-scale production of well-defined scaffolds for implants and membranes using fibers ranging from nanometer up to micrometer scale.

    Applying specific polymers, IME’s advanced equipment creates fiber-based medical device solutions that mimic the natural human extracellular matrix in nanometer and micrometer format for implants and membranes in the human body. Human cells recognize this artificial matrix (scaffold) as the body’s own facilitating the repair of the damaged tissue for heart valves, blood vessels, nerves, tendons, skin, and bone, etc., the company reported in a news release. This is in contrast to implants and membranes of traditional structures, which are seen as foreign and therefore can lead to scar tissue or rejection phenomena, it explained. 

    “The global launch of our state-of-the art production platform is testimony to our strong belief in the strategic goal of becoming the leading developer and producer of the most advanced electrospinning equipment for both large-scale production and R&D purpose and  broadens our trusted partnership worldwide in co-developing electrospun medical devices, which are seen as true game changers in the MedTech industry,” stated Judith Heikoop, managing director of IME Medical Electrospinning, in a news release.

    Added Ramon Solberg, founder and managing director of IME Medical Electrospinning: “This technology enables the large-scale manufacturing of reproducible and scalable fiber-based scaffolds, the wonderful pieces of art that will substantially transform the medical device market for a wide variety of medical applications and thus revolutionize regenerative medicine.”

    The MediSpin XL platform has reportedly eliminated all the important factors that might distort the electrospinning process, enabling an optimal process set-up and stability, including climate control and on-line quality monitoring measurements, ensuring a consistent end-product, the company claimed.

    [Image courtesy of IME MEDICAL ELECTROSPINNING]

    Editor's Note: If you have news you’d like to submit for potential inclusion in future weekly roundups, please send a press release and any related images to [email protected] with the subject line “Supplier Stories.”

  • Masy BioServices is expanding its validation services in North Carolina’s Research Triangle Park, with two Senior Validation Project Leads, Greg LaBruyere and Mike Rose, joining Masy’s growing validation team. The company offers an array of services to the life sciences community, including calibration of primary standards and critical test equipment, validation and IQ/OQ/PQ of environmental chambers, autoclaves, and thermal warehouse mapping, and lab equipment rentals and sales. As a cGMP biorepository, it offers secure and tightly controlled temperature storage from -196˚C to 70˚C, including all ICH stability conditions, for a variety of materials including bio pharmaceuticals, cell banks, tissues, compounds, vaccines, and medical devices.

    “Greg and Mike are welcome additions to the Masy team,” said Steve Lane, Chief Executive Officer, Masy BioServices, in a news release. “Both have held senior positions supporting GMP operations in quality assurance and validation. Their expertise, combined with their reputation in the region, will greatly benefit our customers by having a local Masy presence.”

    The company maintains headquarters in Pepperell, MA, and offices in Hatfield, PA, and Rockaway, NJ.

    [Logo courtesy of MASY BIOSERVICES]

    Editor's Note: If you have news you’d like to submit for potential inclusion in future weekly roundups, please send a press release and any related images to [email protected] with the subject line “Supplier Stories.”

  • The NovaGuard SA Pro safety system from West Pharmaceutical Services Inc. has won an award at the India Packaging Awards for Excellence in Enhanced User Experience and Excellence in Packaging Design – Shapes and Structures. 

    The NovaGuard SA Pro 1mL device has FDA 510k clearance in the United States and meets the European 2010/32/EU directive for the prevention of sharps injuries. It is a single-use accessory for prefilled ISO standard 1-mL-long staked-needle syringes.

    "West is honored to receive this prestigious recognition for our NovaGuard SA Pro needle safety system, which is designed to help prevent accidental needlestick injuries," said Eric Resnick, Vice President & Chief Technology Officer, Innovation & Technology at West, in a news release. "We appreciate that needlestick injuries are a serious concern for healthcare practitioners, so we developed the NovaGuard system to provide care providers with greater control and protection from potentially life-threatening exposure to harmful diseases when administering injections."  

    The NovaGuard SA Pro 1mL device can be deployed using a single-handed technique and was designed to prevent pre-activation during the handling of prefilled syringes (PFS), the company reported. The design also facilitates easy assembly of glass prefilled syringes with minimal change parts and changeover time to existing assembly equipment for manufacturers. Additional features include:

    • Tamper resistant functionality
    • Low syringe snap-in force for assembly with PFS
    • Compatibility with standard plunger rods

    The awards were held May 21, 2019, during the UBM InnoPack Pharma Conference in Mumbai.

    [Image courtesy of WEST PHARMACEUTICAL SERVICES INC.]

    Editor's Note: If you have news you’d like to submit for potential inclusion in future weekly roundups, please send a press release and any related images to [email protected] with the subject line “Supplier Stories.”

  • SYNEO reports that the United States Patent Office has issued the company a patent that grants the company exclusive rights to the utilization of its two-stage force measuring system in Manual Electric Press and Automatic Electric Press (Press-fit) machine applications. The company designs and manufactures machine and cutting tool products for the medical device and electronics manufacturing services (EMS) industries.  

    U.S. Patent No. 10267695 covers the technology behind SYNEO’s two-stage force measuring system that enhances press force resolution and sensitivity in force curves of compliant pin pressing applications used in the electronics manufacturing services and printed circuit board (PCB) assembly industry, the company reported in a news release.

    “This patent is another step in solidifying SYNEO as the leader in “Press-fit” applications domestically and internationally,” said Trent Steckler, SYNEO VP of engineering, in the release. “With automotive, aerospace and industrial electronics, along with Telecom/Datacom increasing their utilization of compliant pin or “press-fit” connector applications, this patent further positions SYNEO as the go-to solution for these advanced application needs.” 

    [Logo courtesy of SYNEO]

    Editor's Note: If you have news you’d like to submit for potential inclusion in future weekly roundups, please send a press release and any related images to [email protected] with the subject line “Supplier Stories.”

Daphne Allen

Daphne Allen is editor-in-chief of MD+DI. She previously served as executive editor of Pharmaceutical & Medical Packaging News, which serves as the pharmaceutical and medical device channel of Packaging Digest. Daphne has covered medical device manufacturing, packaging, labeling, and regulatory issues as well as pharmaceutical packaging and labeling for more than 20 years. She is also a member of the Institute of Packaging Professionals's Medical Device Packaging Technical Committee. Follow her on Twitter at @daphneallen.

 

500 characters remaining